Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Wayland Group Corp MRRCF

Wayland Group Corp, formerly Maricann Group Inc produces and sells medical marijuana. It is currently engaged in cultivation, extraction, analytics and production facilities to elevate offerings and prepare for growth into the adult-use cannabis market in Canada.


GREY:MRRCF - Post by User

Bullboard Posts
Comment by mudpuppyon Feb 20, 2019 10:54pm
100 Views
Post# 29391846

RE:yearly revenue: 24M grams flower from phase 1

RE:yearly revenue: 24M grams flower from phase 1maybe this will help clarify revenue update........

Q1: anticipated revenue 1st quarter $2,700,000
from previous harvest not discussed in corporate update

Q2:
anticipated revenue 2nd quarter, $6,900,000
The Company is currently harvesting 8,200 plants, with product from these plants anticipated to be ready for the market no earlier than April  ie Q2
and planted an additional 21,700 plants and will re-fill the current harvested room with 8,300 plants in mid-March in order to fill the balance of the currently licensed area.

so total 30,000 plants x 50 gms = 1,500,000 gms x $4.6 gm = $6,900,000 in Q2
(
30,000 plants equals 3.5 rooms so other 4.5 rooms are not being utilized for growing in Q2)


 Q3: anticipated revenue 3rd quarter $7,700,000
 The Company expects to request inspection for readiness by Health Canada of the Phase 1-A area in March of this year.
There are more licenses required for 1-A so the prior pr suggesting 8 rooms were fully licensed is not true.  This accounts for Q3 being almost same revenue as Q2 .

Q4:anticipated revenue 4th quarter  $20,600,000
Now licenses have been acquired and more rooms can be cultivated so revenue jumps to $20.6M = $80M annualized

Q1 2020?: once fully licensed for Phase 1-A through Phase 1-D will be able to produce 23,731 kg
in previous post, I figured this to be about $105,000,000 annualized at $4.4/gm






mudpuppy wrote: https://reports.cannabisbenchmarks.com/

usa wholesale benchmarks:
indoor flower $1513/lb,  sells for 50% more than greenhouse flower. which sells for 50% more than outdoor.

wayland pr expected production for phase one=24M grams=53,000 lbs x $1513 lb= $80M usd=$105M cad/yr revenue just from langton

using usa wholesale revenue figure at $1513usd/lb converts to $4.4 cad/gm  
margins higher in germany so  $4.4 cad/gm is low


Bullboard Posts